Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Boulware

Showing results (271-280 of 350) with videos related to

Pageof 35
Sort By:
The Journal of Infectious Diseases|December 11, 2014
Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2024
The Diagnostic Performance of the Visitect Advanced Disease Point-Of-Care CD4 Platform: A Pragmatic, Mixed-Methods, Multisite Validation, Costing, and Qualitative AnalysisElizabeth Nalintya, Preethiya Sekar, Olive L Namakula, et al.
The Journal of Infectious Diseases|January 13, 2026
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous MeningitisAnna L Wilt, David B Meya, Fiona V Cresswell, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple EtiologiesNathan C Bahr, Caleb P Skipper, Kathy Huppler-Hullsiek, et al.
Tropical Medicine & International Health : TM & IH|October 5, 2016
Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, BrazilJosé E Vidal, Carolina Toniolo, Adriana Paulino, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Pageof 35

Showing results (271-280 of 350) with videos related to

Sort By:
Pageof 35
The Journal of Infectious Diseases|December 11, 2014
Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndromeDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 19, 2024
The Diagnostic Performance of the Visitect Advanced Disease Point-Of-Care CD4 Platform: A Pragmatic, Mixed-Methods, Multisite Validation, Costing, and Qualitative AnalysisElizabeth Nalintya, Preethiya Sekar, Olive L Namakula, et al.
The Journal of Infectious Diseases|January 13, 2026
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous MeningitisAnna L Wilt, David B Meya, Fiona V Cresswell, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple EtiologiesNathan C Bahr, Caleb P Skipper, Kathy Huppler-Hullsiek, et al.
Tropical Medicine & International Health : TM & IH|October 5, 2016
Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, BrazilJosé E Vidal, Carolina Toniolo, Adriana Paulino, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Pageof 35